Return to Search
<p>HPMS - 1/20/2022 - Prescription Drug Event Guidance Related to Oral Antiviral Drugs for Treatment of COVID-19 that Receive U.S. Food and Drug Administration Emergency Use Authorization and are Procured by the U.S. Government</p>\r\n
Guidance for Part D
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 20, 2022
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.